Gilead Sciences And Cancer Treatment Company Immunomedics In $20B Deal By: TalkMarkets September 13, 2020 at 06:49 AM EDT Gilead Sciences Inc. is gearing up to purchase drug innovator Immunomedics Inc. for a price tag exceeding $20 billion. Read More >> Related Stocks: Gilead Sciences Immunomedics Inc
